Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis

E. M. Bernard, Brian Wong, D. Armstrong

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Because routine analytical methods cannot differentiate D- from L-arabinitol, a combined microbiological and gas chromatographic method was developed to study the stereoisomeric configuration of the arabinitol in humans and rats with invasive candidiasis. D-Arabinitol was defined as the difference between arabinitol concentrations measured with and without incubation with 5.0 x 105 blastospores of Candida tropicalis strain CT 12 at 37 C for 24 hr. The yeast consumed at least 95% of the D-arabinitol and none of the L-arabinitol added to normal serum and urine. D-Arabinitol as a fraction of D,L-arabinitol was 0.43 ± 0.15 (mean ± SD) in the urine of 10 normal humans, 0.82 ± 0.12 in the serum or urine of five patients with cancer and invasive candidiasis (P <.001), and 1.0 in the kidneys of rats with candidiasis. Because most or all of the excess arabinitol in body fluids or tissues in candidiasis was the D isomer, which is produced by fungal metabolism, stereospecific quantitation of arabinitol should improve the sensitivity of this approach to diagnosis of candidiasis.

Original languageEnglish (US)
Pages (from-to)711-715
Number of pages5
JournalJournal of Infectious Diseases
Volume151
Issue number4
StatePublished - 1985
Externally publishedYes

Fingerprint

Invasive Candidiasis
Urine
Serum
Candidiasis
Candida tropicalis
arabitol
Body Fluids
Yeasts
Gases
Kidney

ASJC Scopus subject areas

  • Immunology
  • Public Health, Environmental and Occupational Health

Cite this

Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis. / Bernard, E. M.; Wong, Brian; Armstrong, D.

In: Journal of Infectious Diseases, Vol. 151, No. 4, 1985, p. 711-715.

Research output: Contribution to journalArticle

Bernard, E. M. ; Wong, Brian ; Armstrong, D. / Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis. In: Journal of Infectious Diseases. 1985 ; Vol. 151, No. 4. pp. 711-715.
@article{37025dc26b9c4b16bde396566bf94189,
title = "Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis",
abstract = "Because routine analytical methods cannot differentiate D- from L-arabinitol, a combined microbiological and gas chromatographic method was developed to study the stereoisomeric configuration of the arabinitol in humans and rats with invasive candidiasis. D-Arabinitol was defined as the difference between arabinitol concentrations measured with and without incubation with 5.0 x 105 blastospores of Candida tropicalis strain CT 12 at 37 C for 24 hr. The yeast consumed at least 95{\%} of the D-arabinitol and none of the L-arabinitol added to normal serum and urine. D-Arabinitol as a fraction of D,L-arabinitol was 0.43 ± 0.15 (mean ± SD) in the urine of 10 normal humans, 0.82 ± 0.12 in the serum or urine of five patients with cancer and invasive candidiasis (P <.001), and 1.0 in the kidneys of rats with candidiasis. Because most or all of the excess arabinitol in body fluids or tissues in candidiasis was the D isomer, which is produced by fungal metabolism, stereospecific quantitation of arabinitol should improve the sensitivity of this approach to diagnosis of candidiasis.",
author = "Bernard, {E. M.} and Brian Wong and D. Armstrong",
year = "1985",
language = "English (US)",
volume = "151",
pages = "711--715",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis

AU - Bernard, E. M.

AU - Wong, Brian

AU - Armstrong, D.

PY - 1985

Y1 - 1985

N2 - Because routine analytical methods cannot differentiate D- from L-arabinitol, a combined microbiological and gas chromatographic method was developed to study the stereoisomeric configuration of the arabinitol in humans and rats with invasive candidiasis. D-Arabinitol was defined as the difference between arabinitol concentrations measured with and without incubation with 5.0 x 105 blastospores of Candida tropicalis strain CT 12 at 37 C for 24 hr. The yeast consumed at least 95% of the D-arabinitol and none of the L-arabinitol added to normal serum and urine. D-Arabinitol as a fraction of D,L-arabinitol was 0.43 ± 0.15 (mean ± SD) in the urine of 10 normal humans, 0.82 ± 0.12 in the serum or urine of five patients with cancer and invasive candidiasis (P <.001), and 1.0 in the kidneys of rats with candidiasis. Because most or all of the excess arabinitol in body fluids or tissues in candidiasis was the D isomer, which is produced by fungal metabolism, stereospecific quantitation of arabinitol should improve the sensitivity of this approach to diagnosis of candidiasis.

AB - Because routine analytical methods cannot differentiate D- from L-arabinitol, a combined microbiological and gas chromatographic method was developed to study the stereoisomeric configuration of the arabinitol in humans and rats with invasive candidiasis. D-Arabinitol was defined as the difference between arabinitol concentrations measured with and without incubation with 5.0 x 105 blastospores of Candida tropicalis strain CT 12 at 37 C for 24 hr. The yeast consumed at least 95% of the D-arabinitol and none of the L-arabinitol added to normal serum and urine. D-Arabinitol as a fraction of D,L-arabinitol was 0.43 ± 0.15 (mean ± SD) in the urine of 10 normal humans, 0.82 ± 0.12 in the serum or urine of five patients with cancer and invasive candidiasis (P <.001), and 1.0 in the kidneys of rats with candidiasis. Because most or all of the excess arabinitol in body fluids or tissues in candidiasis was the D isomer, which is produced by fungal metabolism, stereospecific quantitation of arabinitol should improve the sensitivity of this approach to diagnosis of candidiasis.

UR - http://www.scopus.com/inward/record.url?scp=0021923152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021923152&partnerID=8YFLogxK

M3 - Article

C2 - 3973418

AN - SCOPUS:0021923152

VL - 151

SP - 711

EP - 715

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -